Medicines labeled for the same conditions
Alternatives to capecitabine
5 other medicines are given the same way (oral) and in the same FDA class as capecitabine or labeled mainly for the same use (colorectal cancer); 1 is in its class, nucleoside metabolic inhibitors: tipiracil and trifluridine; the others include 2 kinase inhibitors (FDA labels read October 8, 2026).
Which medicines are labeled for the same conditions as capecitabine?
Colorectal cancer lists all 23 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Capecitabinenucleoside metabolic inhibitor | this medicine | 18 labelers | $0.456 per tablet 500 mg tablet | Yes | No current entry |
| Tipiracil and trifluridinethymidine phosphorylase inhibitor · same class | Colorectal cancer | none listed | n/a | No | No current entry |
| Tucatinibkinase inhibitor | Breast cancer, Colorectal cancer | none listed | n/a | No | No current entry |
| Fruquintinib | Colorectal cancer | none listed | n/a | No | No current entry |
| Encorafenib | Colorectal cancer | none listed | n/a | No | No current entry |
| Regorafenibkinase inhibitor | Colorectal cancer | none listed | n/a | Yes | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Capecitabine: the full record
- label, generics, price, shortages, recalls